As filed
with the Securities and Exchange Commission on December 17, 2009
Registration
No. 333-
SECURITIES
AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-8
REGISTRATION
STATEMENT UNDER
THE
SECURITIES ACT OF 1933
CANTEL
MEDICAL CORP.
(Exact name of registrant as specified in its charter)
Delaware
|
|
CANTEL
MEDICAL CORP.
150
Clove Road
Little
Falls, New Jersey 07424
(973)
890-7220
|
|
22-1760285
|
(State or other
jurisdiction
of incorporation or organization)
|
|
(Address of
principal executive offices)
|
|
(I.R.S. employer
identification
number)
|
Cantel Medical Corp. 2006 Equity Incentive Plan
(Full Title of Plan)
Eric
W. Nodiff, Esq.
Senior
Vice President and General Counsel
Cantel
Medical Corp.
150
Clove Road
Little
Falls, New Jersey 07424
(973)
890-7220
(Name, address and
telephone number, including area code, of agent for service)
CALCULATION
OF REGISTRATION FEE
Title of each
Class of
Securities to be Registered
|
|
Amount to
be Registered (1)
|
|
Proposed
Maximum Offering
Price Per Share (2)
|
|
Proposed Maximum
Aggregate Offering
Price (2)
|
|
Amount of
Registration
Fee
|
|
Common
Stock, par value $.10
|
|
385,000 shares
|
|
$
|
19.785
|
|
$
|
7,617,225
|
|
$
|
425.04
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) This Registration Statement also covers any additional shares
of Common Stock that become issuable under the Plan by reason of any stock
dividend, stock split, recapitalization or any other similar transaction
effected without the receipt of consideration that results in an increase in
the number of the Registrants outstanding shares of Common Stock.
(2) Estimated solely for the purpose of calculating the
registration fee in accordance with Rule 457(h) under the Securities
Act of 1933, as amended, and based on the average of the high and low sales
prices of Common Stock reported on the New York Stock Exchange on December 11,
2009.
Indicate by check mark
whether the registrant is a large accelerated filer, an accelerated filer, a
non-accelerated filer, or a smaller reporting company. See the definitions of large accelerated
filer, accelerated filer, and smaller reporting company in Rule 12b-2
of the Exchange Act. (Check one)
Large
accelerated filer
o
|
|
Accelerated filer
x
|
|
Non-accelerated filer
o
|
|
Smaller reporting company
o
|
EXPLANATORY NOTE
This
Registration Statement on Form S-8 is filed by Cantel Medical Corp. (the Company
or the Registrant), to register an additional 385,000 shares of the Companys
common stock, par value $0.10 per share (the Common Stock), for issuance
pursuant to awards granted under the Companys 2006 Equity Incentive Plan (as
amended, the Plan). The Company previously filed Registration Statements on Form S-8
(File No. 333-140388 and File No. 333-157033) to register an
aggregate of 1,700,000 shares of Common Stock under the Plan.
At
the Annual Meeting of Stockholders of the Company held on December 17,
2009 (the Annual Meeting), the Companys stockholders approved an amendment
to the Plan to increase the number of shares of Common Stock authorized to be
issued under the Plan by 385,000 to a total of 2,085,000 shares.
In
accordance with General Instruction E of Form S-8, the contents of the
Companys earlier Registration Statements on Form S-8 (Registration No. 333-140388
and Registration No. 333-157033) are incorporated herein by reference,
except that certain provisions contained in Part II of such earlier
Registration Statements are modified as set forth in this Registration
Statement.
PART I
INFORMATION REQUIRED IN PROSPECTUS
All
information required by Part I of Form S-8 to be contained in the prospectus
is omitted from this registration statement in accordance with Rule 428
under the Securities Act of 1933, as amended (the Securities Act).
PART II
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
Item 3.
Incorporation
of Documents by Reference.
The
following documents filed with the Securities and Exchange Commission are
incorporated herein by reference:
(a)
The Companys Annual Report on Form 10-K for the fiscal year ended July 31,
2009 filed pursuant to Section 13(a) or 15(d) of the Securities
Exchange Act of 1934 (the Exchange Act);
(b)
The Companys Quarterly Report on Form 10-Q for the quarter ended October 31,
2009 filed on December 10, 2009;
(c)
The Companys Current Reports on Form 8-K filed on August 24, 2009, September 17,
2009, October 9, 2009, November 20, 2009 and December 9, 2009;
and
(d)
The Companys Registration Statement on Form 8-A filed on April 10,
1972 registering the Companys Common Stock under Section 12 of the
Exchange Act, which contains a description of the Common Stock.
All
documents subsequently filed by the Company pursuant to Sections 13(a),
13(c), 14 and 15(d) of
2
the
Exchange Act, prior to the filing of a post-effective amendment to this
registration statement which indicates that all securities offered hereby have
been sold or which deregisters all securities then remaining unsold, shall be
deemed to be incorporated by reference in this registration statement and to be
a part hereof from the date of filing of such documents.
Any
statement contained herein or in a document incorporated or deemed to be
incorporated by reference herein shall be deemed to be modified or superseded
for purposes of this Registration Statement to the extent that a statement
contained herein or in any other subsequently filed document which also is or
is deemed to be incorporated by reference herein modifies or supersedes such
earlier statement. Any such statement so modified or superseded shall not be
deemed, except as so modified or superseded, to constitute a part of this
Registration Statement.
Item 5.
Interests of Named Experts and Counsel.
The legality of the shares of common stock registered hereunder has
been passed upon by Eric W. Nodiff, the Companys Senior Vice President and
General Counsel, who owns shares of Common Stock and options to purchase
additional shares of the Common Stock, and is eligible to participate in the
Plan.
Item 6.
Indemnification of Directors and Officers.
Section 145 of the General Corporation Law of the State of
Delaware authorizes a court to award or a corporations board of directors to
grant indemnification to directors and officers in terms that are sufficiently
broad to permit indemnification under certain circumstances for liabilities
(including reimbursement for expenses incurred) arising under the Securities
Act.
Article Fifteenth of the Companys Amended and Restated
Certificate of Incorporation states that no director of the Company shall be
liable to the Company or its stockholders for monetary damages for breach of
fiduciary duty as a director, provided that Article Fifteenth does not
eliminate or limit the liability of a director (i) for any breach of the
directors duty of loyalty to the Company or its stockholders, (ii) for
acts or omissions not in good faith or which involve intentional misconduct or
a knowing violation of law, (iii) under Section 174 of the DGCL, or (iv) for
any transaction from which the director derived an improper personal benefit.
Article Thirteenth of the Companys Amended and Restated
Certificate of Incorporation states that the Company shall, to the fullest
extent permitted by Section 145 of the DGCL, indemnify any and all persons
it has the power to indemnify under Section 145 from and against any and
all of the expenses, liabilities or other matters referred to in or covered by Section 145.
The right to indemnification will continue as to a person who has ceased to be
a director, officer, employee or agent and will inure to the benefit of the heirs,
executors and administrators of such a person. The indemnification provided
under Article Thirteenth will not be deemed exclusive of any other rights
of which those seeking indemnification may be entitled under any by-law,
agreement, vote of stockholders or disinterested directors or otherwise.
The
Companys By-laws, as amended, also provides that the Companys directors and
officers shall be indemnified against liabilities arising from their service as
directors or officers to the fullest extent permitted by the DGCL.
The Company maintains
insurance for the benefit of its directors and officers and the directors and
officers of its subsidiaries, insuring such persons against certain
liabilities, including liabilities arising under the
3
securities laws. In
addition, the Company has entered into Indemnification Agreements with certain
of its directors and officers which provide for indemnification from liability
to the full extent permitted by the DGCL.
Item 8.
Exhibits
Exhibit
Number
|
|
Description of Document
|
|
|
|
4
|
|
2006
Equity Incentive Plan, as amended.
|
5
|
|
Opinion
of Eric W. Nodiff, Esq., General Counsel of Registrant.
|
10
|
|
Form of
Restricted Stock Agreement under the Registrants 2006 Equity Incentive Plan.
|
23.1
|
|
Consent
of Ernst & Young LLP, Independent Registered Public Accounting Firm.
|
23.2
|
|
Consent
of Eric W. Nodiff, Esq. (included in his opinion filed as
Exhibit 5).
|
24
|
|
Power
of Attorney (contained on the signature page to this registration
statement).
|
Item 9. Undertakings
(a)
The Registrant
hereby undertakes:
(1)
To file, during
any period in which offers or sales are being made, a post-effective amendment
to this Registration Statement:
(i)
To include any
prospectus required by section 10(a)(3) of the Securities Act;
(ii)
To reflect in
the prospectus any facts or events arising after the effective date of this
Registration Statement (or the most recent post-effective amendment thereof)
which, individually or in the aggregate, represent a fundamental change in the
information set forth in this Registration Statement. Notwithstanding the
foregoing, any increase or decrease in volume of securities offered (if the
total dollar value of securities offered would not exceed that which was registered)
and any deviation from the low or high end of the estimated maximum offering
range may be reflected in the form of prospectus filed with the Commission
pursuant to Rule 424(b) if, in the aggregate, the changes in volume
and price represent no more than 20 percent change in the maximum aggregate
offering price set forth in the Calculation of Registration Fee table in the
effective Registration Statement; and
(iii)
To include any
material information with respect to the plan of distribution not previously
disclosed in this Registration Statement or any material change to such
information in this Registration Statement;
provided, however
, that paragraphs (a)(1)(i) and
(a)(1)(ii) above do not apply if the information required to be
included in a post-effective amendment by those paragraphs is contained in
reports filed with or furnished to the Commission by the Registrant pursuant to
section 13 or section 15(d) of the Exchange Act that are
incorporated by reference in this Registration Statement;
(2)
That, for the
purpose of determining any liability under the Securities Act, each such
post-effective amendment shall be deemed to be a new registration statement
relating to the securities offered
4
therein, and the offering of such securities at that time shall be
deemed to be the initial
bona fide
offering
thereof; and
(3)
To remove from
registration by means of a post-effective amendment any of the securities being
registered which remain unsold at the termination of the offering.
(b)
The Registrant
hereby undertakes that, for purposes of determining any liability under the
Securities Act, each filing of the Registrants annual report pursuant to
section 13(a) or section 15(d) of the Exchange Act (and,
where applicable, each filing of an employee benefit plans annual report
pursuant to section 15(d) of the Exchange Act) that is incorporated
by reference in this Registration Statement shall be deemed to be a new
registration statement relating to the securities offered therein, and the
offering of such securities at that time shall be deemed to be the initial
bona fide
offering thereof.
(c)
Insofar as
indemnification for liabilities arising under the Securities Act may be
permitted to directors, officers and controlling persons of the Registrant
pursuant to the foregoing provisions, or otherwise, the Registrant has been
advised that in the opinion of the Securities and Exchange Commission such
indemnification is against public policy as expressed in the Act and is,
therefore, unenforceable. In the event that a claim for indemnification against
such liabilities (other than the payment by the Registrant of expenses incurred
or paid by a director, officer or controlling person of the Registrant in the successful
defense of any action, suit or proceeding) is asserted by such director,
officer or controlling person in connection with the securities being
registered, the Registrant will, unless in the opinion of its counsel the
matter has been settled by controlling precedent, submit to a court of
appropriate jurisdiction the question whether such indemnification by it is
against public policy as expressed in the Act and will be governed by the final
adjudication of such issue.
5
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
registrant certifies that it has reasonable grounds to believe that it meets
all of the requirements for filing on Form S-8 and has duly caused this
registration statement to be signed on its behalf by the undersigned, thereunto
duly authorized, in the city of Little Falls, state of New Jersey, on this 17
th
day of December, 2009.
|
CANTEL MEDICAL CORP.
|
|
|
|
|
|
By:
|
/s/ Andrew A. Krakauer
|
|
|
Name:
|
Andrew A. Krakauer
|
|
|
Title:
|
President and CEO
|
POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE PRESENTS
, that each
person whose signature appears below constitutes and appoints Andrew A.
Krakauer and Eric W. Nodiff, and each of them, his true and lawful
attorney-in-fact and agent, with full power of substitution and resubstitution,
for him and in his name, place and stead, in any and all capacities, to sign
any or all amendments (including post-effective amendments) to this
Registration Statement, and to file the same, with all exhibits thereto, and
other documents in connection therewith, with the Securities and Exchange
Commission, granting unto said attorneys-in-fact and agents, and each of them,
full power and authority to do and perform each and every act and thing
requisite and necessary to be done in and about the premises, as fully to all
intents and purposes as he might or could do in person, hereby ratifying and
confirming all that said attorneys-in-fact and agents or any of them or their
substitutes may lawfully do or cause to be done by virtue hereof.
Pursuant
to the requirements of the Securities Act of 1933, this Registration Statement
has been signed by the following persons in the capacities and on the dates
indicated.
SIGNATURE
|
|
TITLE
|
|
DATE
|
|
|
|
|
|
PRINCIPAL
EXECUTIVE
OFFICER:
|
|
|
|
|
/s/
Andrew A. Krakauer
|
|
|
|
|
Andrew
A. Krakauer
|
|
President and CEO
|
|
December 17, 2009
|
PRINCIPAL
FINANCIAL AND
ACCOUNTING OFFICER:
/s/
Craig A. Sheldon
|
|
|
|
|
Craig A. Sheldon
|
|
Senior
Vice President,
Chief
Financial Officer and Treasurer
|
|
December 17,
2009
|
6
DIRECTORS:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
/s/
Charles M. Diker
|
|
|
|
|
Charles M. Diker
|
|
Chairman
of the Board and Director
|
|
December 17,
2009
|
|
|
|
|
|
/s/
Alan J. Hirschfield
|
|
|
|
|
Alan J. Hirschfield
|
|
Director
|
|
December 17,
2009
|
|
|
|
|
|
/s/
Robert L. Barbanell
|
|
|
|
|
Robert L. Barbanell
|
|
Director
|
|
December 17,
2009
|
|
|
|
|
|
/s/
Alan R. Batkin
|
|
|
|
|
Alan R. Batkin
|
|
Director
|
|
December 17,
2009
|
|
|
|
|
|
/s/
Joseph M. Cohen
|
|
|
|
|
Joseph M. Cohen
|
|
Director
|
|
December 17,
2009
|
|
|
|
|
|
/s/
Mark N. Diker
|
|
|
|
|
Mark N. Diker
|
|
Director
|
|
December 17,
2009
|
|
|
|
|
|
/s/
George L. Fotiades
|
|
|
|
|
George L. Fotiades
|
|
Vice
Chairman and Director
|
|
December 17,
2009
|
|
|
|
|
|
/s/
Andrew A. Krakauer
|
|
|
|
|
Andrew A. Krakauer
|
|
Director
|
|
December 17,
2009
|
|
|
|
|
|
/s/
Bruce Slovin
|
|
|
|
|
Bruce Slovin
|
|
Director
|
|
December 17,
2009
|
7
EXHIBIT INDEX
Exhibit
Number
|
|
Description of Document
|
|
|
|
4
|
|
2006
Equity Incentive Plan, as amended
|
5
|
|
Opinion
of Eric W. Nodiff, Esq., General Counsel of Registrant.
|
10
|
|
Form of
Restricted Stock Agreement
|
23.1
|
|
Consent
of Ernst & Young LLP, Independent Registered Public Accounting Firm.
|
23.2
|
|
Consent
of Eric W. Nodiff, Esq. (included in his opinion filed as
Exhibit 5).
|
24
|
|
Power
of Attorney (contained on the signature page to this registration
statement).
|
8
Cantel Medical (NYSE:CMD)
Historical Stock Chart
From Jun 2024 to Jul 2024
Cantel Medical (NYSE:CMD)
Historical Stock Chart
From Jul 2023 to Jul 2024